Trials & research

Explore the regional portfolio.

Search representative studies by recruitment stage, research approach, condition and location.

7 representative studies

Recruiting now
EEDTC–01

Early Alzheimer’s treatment study

Early Alzheimer’s disease

Phase
Phase II
Approach
Therapeutic drug trials
Visits
8 clinic visits over 12 months
Sites
Cambridge · Essex
Recruiting now
EEDTC–02

Blood biomarker validation

Mild cognitive impairment

Phase
Observational
Approach
Biomarker & imaging
Visits
2 clinic visits
Sites
Norfolk · Suffolk · Cambridge
Recruiting now
EEDTC–03

Rare dementia cohort

FTD and rare dementias

Phase
Natural history
Approach
Observational
Visits
Annual assessment
Sites
Cambridge · Remote follow-up
In set-up
EEDTC–04

Tau-targeting therapy

Early Alzheimer’s disease

Phase
Phase Ib
Approach
Therapeutic drug trials
Visits
Monthly over 18 months
Sites
Cambridge · Hertfordshire
In set-up
EEDTC–05

Digital cognitive outcomes

Prodromal dementia

Phase
Phase II methods
Approach
Biomarker & imaging
Visits
Hybrid participation
Sites
Region-wide
Feasibility & Pipeline
EEDTC–06

Intrathecal gene-silencing study

Genetic dementia

Phase
Phase I
Approach
Therapeutic drug trials
Visits
Intensive early-phase schedule
Sites
Cambridge anchor hub
Feasibility & Pipeline
EEDTC–07

Prevention platform

At-risk populations

Phase
Feasibility
Approach
Observational
Visits
Protocol in development
Sites
Six-county assessment